The Asia Pacific Dermal Fillers Market should witness market growth of 9.1% CAGR during the forecast period (2023-2029).
Due to new developments in rejuvenation and aesthetic enhancements that were previously only possible through surgery, dermal fillers have recently seen a sharp increase in popularity. Dermal fillers exhibit immediate benefits in aesthetic volume replacement treatments due to their less invasive nature. Some market participants are working on cutting-edge technology, new items, and some are already in the pipeline. New advanced products have been developed to accelerate the market expansion for dermal fillers.
Due to the explosion of social media, factors such as the benefit of product comparison, an increase in the desire to keep young looks, and an uptick in the anti-aging craze all contribute to the market's expansion. Under the eyes, tear trough filler is an injectable procedure. It serves to accentuate the volume under the eyelids. Although other substances might be employed, hyaluronic acid is often the main component of the product most frequently used in this area.
China's demand for medical tourism is expected to surge in the coming years. The rapid expansion of China's economy, which is now one of the largest in the world, has enhanced its reputation as a nation with a cutting-edge healthcare system. This has substantially increased China's medical tourism industry. Government support has also significantly impacted the country's dental tourism growth. It is anticipated that the expanding healthcare infrastructure and elite medical personnel will encourage more individuals to choose to get aesthetic surgeries in this region, boosting the market growth in Asia Pacific.
The China market dominated the Asia Pacific Dermal Fillers Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $779.5 million by 2029. The Japan market is estimated to grow a CAGR of 8.4% during (2023-2029). Additionally, The India market would experience a CAGR of 9.8% during (2023-2029).
Based on Type, the market is segmented into Biodegradable and Non-biodegradable. Based on Product, the market is segmented into Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid (PLLA), Polymethyl-methacrylate Microspheres and Others. Based on End-use, the market is segmented into MedSpa, Cosmetic Surgery Clinics and Hospitals. Based on Application, the market is segmented into Wrinkle Correction, Lip Enhancement, Facial Contouring, Scar Treatment and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioplus Co. Ltd, Bioxis pharmaceuticals, Suneva Medical, Inc., Galderma S.A., Allergan PLC (AbbVie, Inc.), Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.), Revance Therapeutics, Inc., Medytox Inc., Merz Pharma GmbH & Co. KGaA and Prollenium Medical Technologies Inc.
Due to new developments in rejuvenation and aesthetic enhancements that were previously only possible through surgery, dermal fillers have recently seen a sharp increase in popularity. Dermal fillers exhibit immediate benefits in aesthetic volume replacement treatments due to their less invasive nature. Some market participants are working on cutting-edge technology, new items, and some are already in the pipeline. New advanced products have been developed to accelerate the market expansion for dermal fillers.
Due to the explosion of social media, factors such as the benefit of product comparison, an increase in the desire to keep young looks, and an uptick in the anti-aging craze all contribute to the market's expansion. Under the eyes, tear trough filler is an injectable procedure. It serves to accentuate the volume under the eyelids. Although other substances might be employed, hyaluronic acid is often the main component of the product most frequently used in this area.
China's demand for medical tourism is expected to surge in the coming years. The rapid expansion of China's economy, which is now one of the largest in the world, has enhanced its reputation as a nation with a cutting-edge healthcare system. This has substantially increased China's medical tourism industry. Government support has also significantly impacted the country's dental tourism growth. It is anticipated that the expanding healthcare infrastructure and elite medical personnel will encourage more individuals to choose to get aesthetic surgeries in this region, boosting the market growth in Asia Pacific.
The China market dominated the Asia Pacific Dermal Fillers Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $779.5 million by 2029. The Japan market is estimated to grow a CAGR of 8.4% during (2023-2029). Additionally, The India market would experience a CAGR of 9.8% during (2023-2029).
Based on Type, the market is segmented into Biodegradable and Non-biodegradable. Based on Product, the market is segmented into Hyaluronic Acid, Calcium Hydroxylapatite, Polylactic Acid (PLLA), Polymethyl-methacrylate Microspheres and Others. Based on End-use, the market is segmented into MedSpa, Cosmetic Surgery Clinics and Hospitals. Based on Application, the market is segmented into Wrinkle Correction, Lip Enhancement, Facial Contouring, Scar Treatment and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bioplus Co. Ltd, Bioxis pharmaceuticals, Suneva Medical, Inc., Galderma S.A., Allergan PLC (AbbVie, Inc.), Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.), Revance Therapeutics, Inc., Medytox Inc., Merz Pharma GmbH & Co. KGaA and Prollenium Medical Technologies Inc.
Scope of the Study
By Type
- Biodegradable
- Non-biodegradable
By Product
- Hyaluronic Acid
- Calcium Hydroxylapatite
- Polylactic Acid (PLLA)
- Polymethyl-methacrylate Microspheres
- Others
By End-use
- MedSpa
- Cosmetic Surgery Clinics
- Hospitals
By Application
- Wrinkle Correction
- Lip Enhancement
- Facial Contouring
- Scar Treatment
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Bioplus Co. Ltd
- Bioxis pharmaceuticals
- Suneva Medical, Inc.
- Galderma S.A.
- Allergan PLC (AbbVie, Inc.)
- Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- Revance Therapeutics, Inc.
- Medytox Inc.
- Merz Pharma GmbH & Co. KGaA
- Prollenium Medical Technologies Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Dermal Fillers Market by Type
Chapter 5. Asia Pacific Dermal Fillers Market by Product
Chapter 6. Asia Pacific Dermal Fillers Market by End-use
Chapter 7. Asia Pacific Dermal Fillers Market by Application
Chapter 8. Asia Pacific Dermal Fillers Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Bioplus Co. Ltd
- Bioxis pharmaceuticals
- Suneva Medical, Inc.
- Galderma S.A.
- Allergan PLC (AbbVie, Inc.)
- Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- Revance Therapeutics, Inc.
- Medytox Inc.
- Merz Pharma GmbH & Co. KGaA
- Prollenium Medical Technologies Inc.
Methodology
LOADING...
